NASDAQ:AVR Anteris Technologies Global Q1 2025 Earnings Report $9.62 +0.62 (+6.89%) Closing price 05/22/2026 04:00 PM EasternExtended Trading$9.65 +0.03 (+0.35%) As of 05/22/2026 07:52 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. ProfileEarnings HistoryForecast Anteris Technologies Global EPS ResultsActual EPS-$0.61Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AAnteris Technologies Global Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AAnteris Technologies Global Announcement DetailsQuarterQ1 2025Date5/13/2025TimeAfter Market ClosesConference Call DateTuesday, May 13, 2025Conference Call Time6:00PM ETUpcoming EarningsAnteris Technologies Global's Q2 2026 earnings is estimated for Monday, August 10, 2026, based on past reporting schedulesConference Call ResourcesQuarterly Report (10-Q)Interim ReportEarnings HistoryCompany ProfilePowered by Earnings DocumentsQuarterly report(10-Q)Interim report Anteris Technologies Global Earnings HeadlinesAnteris launches $250m at-the-market program to fund structural heart push3 hours ago | tipranks.comAnalysts Have Conflicting Sentiments on These Healthcare Companies: Medtronic (MDT), Immunovant (IMVT) and Anteris Technologies Global Corp. (AVR)May 22 at 9:19 PM | theglobeandmail.comYou cannot escape this realityThe last time something like this happened was 1974 - a secret deal that quietly determined the financial fate of an entire generation. According to Porter Stansberry, founder of one of the largest independent financial research firms in the world, it is happening again. Fortune calls it 'the biggest change to the world's relationship with the dollar' in a generation. Stansberry says Trump's money reset - enacted through executive orders and a treaty signed by 13 nations in December 2025 called Pax Silica - could determine whether you are enriched or quietly impoverished by the shift already underway.May 24 at 1:00 AM | Porter & Company (Ad)Anteris Launches $250 Million At-The-Market Stock ProgramMay 22 at 7:50 PM | tipranks.comBrokerages Set Anteris Technologies Global Corp. (NASDAQ:AVR) Target Price at $15.33May 20, 2026 | americanbankingnews.comAnteris Technologies Global (NASDAQ:AVR) Raised to "Hold" at Wall Street ZenMay 16, 2026 | americanbankingnews.comSee More Anteris Technologies Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Anteris Technologies Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Anteris Technologies Global and other key companies, straight to your email. Email Address About Anteris Technologies GlobalAnteris Technologies Global (NASDAQ:AVR) engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.View Anteris Technologies Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?Workday Validates AI Flywheel: Stock Price Recovery BeginsOverextended, e.l.f. Beauty Is Primed to Rebound in Back HalfDeere Beats Q2 Estimates, But Ag Weakness Weighs on OutlookNVIDIA Price Pullback? Don’t Count on It, Business Is AcceleratingMeta Platforms 10% Layoff Raises a Bigger Question About AI SpendingBiogen Stock Slides After Trial Miss, But Analysts Stay Bullish Upcoming Earnings AutoZone (5/26/2026)Marvell Technology (5/27/2026)PDD (5/27/2026)Synopsys (5/27/2026)Bank Of Montreal (5/27/2026)Bank of Nova Scotia (5/27/2026)Salesforce (5/27/2026)Snowflake (5/27/2026)Autodesk (5/28/2026)Costco Wholesale (5/28/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
